Post-hoc analysis of the CARES trial suggests delayed progression of chronic kidney disease in patients with gout during urate-lowering therapy
Byeongzu Ghang, Jino Park, Ji Sung Lee, Joon Seo Lim, Hyunwoo Kim, David Liew, Jinseok Kim, Duk‐Hee Kang, Bin Yoo
Topics & Concepts
MedicineGoutPost-hoc analysisKidney diseaseInternal medicineDiseaseUric acidIntensive care medicineGout, Hyperuricemia, Uric AcidAlcohol Consumption and Health EffectsCase Reports on Hematomas